25 studies found for:    "von hippel-lindau syndrome"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated
Has Results
Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Sunitinib Malate
2 Terminated
Has Results
Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow
Conditions: Von Hippel-Lindau Syndrome;   Renal Cell Carcinoma;   Hemangioblastoma
Intervention: Drug: SU011248
3 Recruiting Pazopanib in Von Hippel-Lindau (VHL) Syndrome
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Pazopanib
4 Completed Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Ranibizumab
5 Active, not recruiting TKI 258 in Von Hippel-Lindau Syndrome (VHL)
Condition: Von Hippel-Lindau Syndrome
Intervention: Drug: Dovitinib
6 Completed Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome
Conditions: Kidney Cancer;   Von Hippel-lindau Syndrome
Intervention: Genetic: mutation analysis
7 Recruiting Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors
Conditions: Neuroendocrine Tumors;   Von Hippel-Lindau Syndrome;   Hippel-Lindau Disease
Interventions: Drug: 68Gallium DOTATATE;   Drug: 111 In- Octreotide
8 Completed EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
Condition: Hippel-Lindau Disease
Intervention: Drug: EYE001
9 Completed Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease
Conditions: Von Hippel-Lindau Disease;   Hemangioblastoma;   Renal Cell Carcinoma;   Pheochromocytoma;   Pancreatic Neuroendocrine Tumor
Intervention: Other: 89Zr bevacizumab PET scan
10 Recruiting Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)
Condition: Von Hippel-Lindau Disease
Intervention: Drug: Vorinostat
11 Terminated Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
Conditions: Hemangioblastomas;   Von Hippel Lindau Disease
Intervention: Drug: Avastin
12 Completed
Has Results
17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease
Conditions: Hippel-Lindau Disease;   Kidney Cancer
Interventions: Drug: 17 allylamino-17-demethoxygeldanamycin;   Drug: 18 FDG (Fludeoxyglucose 18F);   Drug: [15-O] H2O;   Drug: EPL diluent
13 Completed Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease
Condition: Von Hippel-Lindau Disease
Intervention: Drug: Sunitinib
14 Completed Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584
Conditions: Von Hippel-Lindau Disease;   Central Nervous System Capillary Hemangioblastoma;   Retinal Capillary Hemangioblastoma
Intervention: Drug: PTK787/ZK 222584
15 Active, not recruiting Von Hippel-Lindau Disease Genetic Epidemiology Study
Condition: Hippel Lindau Disease
Intervention:
16 Active, not recruiting Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
Conditions: Hemangioblastoma;   Hippel Lindau Disease
Intervention:
17 Active, not recruiting Phase II Study of Vandetanib in Individuals With Kidney Cancer
Conditions: Renal Cancer;   Von Hippel Lindau
Intervention: Drug: ZACTIMA (Vandetanib) (ZD6474)
18 Recruiting National Eye Institute Biorepository for Retinal Diseases
Conditions: Age-Related Macular Degeneration;   Diabetic Retinopathy;   Von Hippel-Lindau Syndrome;   Retinal Disease;   Retinal Vein Occlusion
Intervention:
19 Recruiting Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
Conditions: Hemangioblastoma;   Hereditary Neoplastic Syndrome;   Hippel Lindau Disease;   Neoplasm;   Renal Cell Carcinoma
Intervention:
20 Completed Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors
Conditions: Deafness;   Kidney Diseases;   Kidney Neoplasms;   Neoplasms;   Retinal Diseases
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results
Indicates status has not been verified in more than two years